The Journal of Immunology, Vol 151, Issue 10 5574-5585, Copyright © 1993 by American Association of Immunologists

ARTICLES

Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products

J Chin and MJ Kostura
Department of Cellular and Molecular Pharmacology, Merck Research Laboratories, Rahway, NJ 07065.

Human blood monocytes synthesize but do not secrete IL-1 beta in response to low doses of bacterial cell-wall products. With this observation, we have developed a two-step staged release assay that separates IL-1 beta synthesis from secretion. This assay can be used to identify secretagogues or inhibitors of IL-1 beta secretion as well as the biochemical events leading to IL-1 beta release. Human blood monocytes are first treated with low (< 50 pg/ml) doses of LPS, which causes the synthesis of intracellular proIL-1 beta. Release of intracellular IL-1 beta can be induced by further treatment with 100 ng/ml of LPS or 1 x 10(6) CFU/ml of heat-killed Staphylococcus aureus. The amount and the efficiency of IL-1 beta secretion in the staged release assay was comparable with that of a standard method of treating blood monocytes with a single dose of 100 ng/ml LPS. Ongoing protein synthesis was not required for IL-1 beta secretion because mature IL-1 beta release occurred in the presence of the protein synthesis inhibitor cycloheximide. We have compared the effects of four different inhibitors of cytokine synthesis on IL-1 beta production in the standard and staged release assays. We find that dexamethasone or IL- 10, when added together with 100 ng/ml LPS, inhibits IL-1 beta production with IC50 levels of 0.2 microM and 2.0 ng/ml, respectively. The IC50 levels increase greater than 50-fold when tested against monocytes pretreated with 50 pg/ml of LPS. These data suggest that dexamethasone and IL-10 have little effect on IL-1 beta secretion. Conversely, the IL-1 beta converting enzyme inhibitor, Ac-Tyr-Val-Ala- Asp-CHO (L-709,049) and the anti-inflammatory agent [5-(4-pyridyl)6(4- fluorophenyl)-2,3-dihydroimidazo(2,1-b)thiazole] (SK&F 86002) inhibited IL-1 beta release in both the standard and staged release assays with IC50 of 1 microM. The data suggest that L-709,049 and SK&F 86002 interfere with steps involved in IL-1 beta secretion, as opposed to synthesis. The results also document a novel method for delineating separate events in the pathway required for IL-1 beta biosynthesis and further distinguish two classes of compounds capable of modulating IL-1 beta secretion.

This article has been cited by other articles:

				C. J. Scotton, F. O. Martinez, M. J. Smelt, M. Sironi, M. Locati, A. Mantovani, and S. Sozzani Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1{beta} System by IL-13 J. Immunol., January 15, 2005; 174(2): 834 - 845. [Abstract] [Full Text] [PDF]

				D. G. Perregaux, K. Bhavsar, L. Contillo, J. Shi, and C. A. Gabel Antimicrobial Peptides Initiate IL-1{beta} Posttranslational Processing: A Novel Role Beyond Innate Immunity J. Immunol., March 15, 2002; 168(6): 3024 - 3032. [Abstract] [Full Text] [PDF]

				E. Carballo, H. Cao, W. S. Lai, E. A. Kennington, D. Campbell, and P. J. Blackshear Decreased Sensitivity of Tristetraprolin-deficient Cells to p38 Inhibitors Suggests the Involvement of Tristetraprolin in the p38 Signaling Pathway J. Biol. Chem., November 2, 2001; 276(45): 42580 - 42587. [Abstract] [Full Text] [PDF]

				D. G. Perregaux, P. McNiff, R. Laliberte, N. Hawryluk, H. Peurano, E. Stam, J. Eggler, R. Griffiths, M. A. Dombroski, and C. A. Gabel Identification and Characterization of a Novel Class of Interleukin-1 Post-Translational Processing Inhibitors J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 187 - 197. [Abstract] [Full Text] [PDF]

				D. G. Perregaux, P. McNiff, R. Laliberte, M. Conklyn, and C. A. Gabel ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1{beta} and IL-18 in Human Blood J. Immunol., October 15, 2000; 165(8): 4615 - 4623. [Abstract] [Full Text] [PDF]

				C. F. Pereira, L. A. Boven, J. Middel, J. Verhoef, and H. S. L. M. Nottet Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions J. Leukoc. Biol., September 1, 2000; 68(3): 423 - 428. [Abstract] [Full Text] [PDF]

				M. A. Moors and S. B. Mizel Proteasome-mediated regulation of interleukin-1{beta} turnover and export in human monocytes J. Leukoc. Biol., July 1, 2000; 68(1): 131 - 136. [Abstract] [Full Text]

				M. Allen, L. Svensson, M. Roach, J. Hambor, J. McNeish, and C. A. Gabel Deficiency of the Stress Kinase p38{alpha} Results in Embryonic Lethality: Characterization of the Kinase Dependence of Stress Responses of Enzyme-deficient Embryonic Stem Cells J. Exp. Med., March 6, 2000; 191(5): 859 - 870. [Abstract] [Full Text] [PDF]

				R. E. Laliberte, J. Eggler, and C. A. Gabel ATP Treatment of Human Monocytes Promotes Caspase-1 Maturation and Externalization J. Biol. Chem., December 24, 1999; 274(52): 36944 - 36951. [Abstract] [Full Text] [PDF]

				D. G. Perregaux and C. A. Gabel Human monocyte stimulus-coupled IL-1beta posttranslational processing: modulation via monovalent cations Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1538 - C1547. [Abstract] [Full Text] [PDF]

				A. A. Khan, T. R. Slifer, and J. S. Remington Effect of Trovafloxacin on Production of Cytokines by Human Monocytes Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1713 - 1717. [Abstract] [Full Text]

				D. G. Perregaux and C. A. Gabel Post-Translational Processing of Murine IL-1: Evidence that ATP-Induced Release of IL-1{alpha} and IL-1{beta} Occurs via a Similar Mechanism J. Immunol., March 1, 1998; 160(5): 2469 - 2477. [Abstract] [Full Text] [PDF]

				D. G. Perregaux, R. E. Laliberte, and C. A. Gabel Human Monocyte Interleukin-1[BETA] Posttranslational Processing. EVIDENCE OF A VOLUME-REGULATED RESPONSE J. Biol. Chem., November 22, 1996; 271(47): 29830 - 29838. [Abstract] [Full Text] [PDF]